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Abstract. The in vitro culture of calvarial osteoblasts from 
neonatal rodents remains an important method for studying the 
regulation of bone formation. The widespread use of transgenic 
mice has created a particular need for a reliable, simple method 
that allows the differentiation and bone‑forming activity 
of murine osteoblasts to be studied. In the present study, we 
established such a method and identified key differences in 
optimal culture conditions between mouse and rat osteoblasts. 
Cells isolated from neonatal rodent calvariae by collagenase 
digestion were cultured for 14‑28 days before staining for 
tissue non-specific alkaline phosphatase (TNAP) and bone 
mineralisation (alizarin red). The reliable differentiation of 
mouse osteoblasts, resulting in abundant TNAP expression and 
the formation of mineralised ‘trabecular‑shaped’ bone nodules, 
occurred only following culture in α minimum essential 
medium (αMEM) and took 21-28 days. Dexamethasone (10 nM) 
inhibited bone mineralisation in the mouse osteoblasts. 
By contrast, TNAP expression and bone formation by rat 
osteoblasts were observed following culture in both αMEM 
and Dulbecco's modified Eagle's medium (DMEM) after 
approximately 14 days (although ~3-fold more effectively in 
αMEM) and was strongly dependent on dexamethasone. Both 
the mouse and rat osteoblasts required ascorbate (50 µg/ml) for 
osteogenic differentiation and β-glycerophosphate (2 mM) for 
mineralisation. The rat and mouse osteoblasts showed similar 
sensitivity to the well‑established inhibitors of mineralisation, 
inorganic pyrophosphate (PPi) and adenosine triphosphate 
(ATP; 1-100 µM). The high efficiency of osteogenic 
differentiation observed following culture in αMEM, compared 
with culture in DMEM possibly reflects the richer formulation 
of the former. These findings offer a reliable technique for 
inducing mouse osteoblasts to form bone in vitro and a more 
effective method for culturing bone‑forming rat osteoblasts.
Introduction
Osteoblasts, the cells responsible for bone formation, are 
derived from mesenchymal stem cells. The in vitro culture of 
osteoblasts constitutes a central part of research into the regu‑
lation of bone cell function. A number of different approaches 
have been developed to study osteoblasts in vitro, including 
primary cell cultures, immortalised osteoblast-like cell lines 
and bone organ cultures. In combination, these methods have 
provided abundant information as to the regulation of osteo‑
blast proliferation, differentiation, survival and function.
A number of different techniques for obtaining primary 
osteoblasts have been described (1-4). These methods use cells 
isolated from a number of different skeletal locations (e.g., long 
bones, calvariae) and animal models (e.g., human, rat, mouse). 
Of these, the in vitro culture of calvarial osteoblasts from 
neonatal rodents remains a main method for studying the regu‑
lation of osteoblast function. The widespread use of transgenics 
has created a particular need for a reliable, simple method that 
allows the differentiation and bone‑forming activity of mouse 
osteoblasts to be investigated directly.
Rat primary bone cell cultures were first described in 1964 
by Peck et al (5), who isolated cells from the parietal and 
frontal bones of fetal and neonatal calvariae using collagenase 
digestion. The isolated cells proliferated in vitro and exhibited 
high tissue non-specific alkaline phosphatase (TNAP) activity; 
however, the cultures were contaminated with other cell types, 
such as fibroblasts. In 1974, Wong and Cohn used sequential 
collagenase digestion to obtain a more homogenous population 
of osteoblasts (6). The first description of the formation of bone 
nodules by differentiating osteoblasts released enzymically 
from calvarial bone and cultured with β‑glycerophosphate 
ascorbate and dexamethasone was by Bellows et al in 1986 (7).
The calvarial osteoblast bone formation assay has a number 
of advantages. Firstly, it allows the key function of osteoblasts, 
namely bone formation, to be studied quantitatively (1). 
Secondly, it enables the processes of bone matrix deposition and 
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mineralisation to be studied separately (8). Thirdly, osteoblast 
activity can be studied in an environment that is relatively free 
from the influence of other cell types normally found in bone, 
such as endothelial and haematopoietic cells. Fourthly, it allows 
the extracellular environment to be tightly controlled (e.g., pH, 
pO2) in a manner which is not possible in vivo or using bone 
organ cultures (9,10). Lastly, osteoblasts can be studied at 
clearly identified stages of differentiation from the immature, 
proliferating cells present early in the cultures through to the 
mature bone‑forming osteoblasts in late‑stage cultures.
There are now numerous reported methods for isolating and 
culturing rodent calvarial osteoblasts. The objectives of this 
study were to: ⅰ) establish clear, simple methods for culturing 
mouse and rat osteoblasts in vitro; and ⅱ) identify the key 
differences between the protocols which need to be taken into 
account to ensure successful osteoblast cultures.
Materials and methods
Reagents. All tissue culture reagents, including Dulbecco's 
modified Eagle's medium (DMEM) (no. 11880), α Minimum 
essential medium (αMEM)  (no. 22571) and fetal calf 
serum (FCS) (no. 102701) were purchased from Invitrogen Life 
Technologies (Paisley, UK); unless otherwise mentioned, other 
reagents were obtained from Sigma-Aldrich (Dorset, UK).
Rat calvarial isolation [trypsin‑collagenase‑collagenase 
(TCC) method]. Primary rat osteoblasts were obtained by 
sequential enzyme digestion of excised calvarial bone from 
2-day-old neonatal Sprague-Dawley rats using a 3-step process 
[(TCC); 1% trypsin in PBS for 10 min; 0.2% collagenase type Ⅱ 
in Hank's balanced salt solution (HBSS) for 30 min; 0.2% colla‑
genase type Ⅱ in HBSS for 60 min]. The first 2 digests were 
discarded and the cells from the final digest were resuspended 
in DMEM supplemented with 10% FCS, 2 mM L-glutamine, 
5% gentimicin, 100 U/ml penicillin, 100 µg/ml streptomycin 
and 0.25 µg/ml amphotericin. The cells were cultured for 
2-4 days in a humidified atmosphere of 5% CO2-95% air at 
37˚C in 75 cm2 flasks until confluent (1 calvarial bone/flask). 
All institutional and national guidelines for the care and use of 
laboratory animals were followed.
Mouse calvarial isolation [collagenase‑collagenase‑ 
EDTA‑collagenase (CCEC) method]. Primary mouse osteo‑
blasts were obtained by sequential enzyme digestion of excised 
calvarial bone from 2- to 4-day-old neonatal mice (129/sv) using 
a 4-step process (CCEC). The first digest (1 mg/ml collagenase 
type Ⅱ in HBSS for 10 min) was discarded. The following 
3 digests (fraction 1, 1 mg/ml collagenase type Ⅱ in HBSS for 
30 min; fraction 2, 4 mM EDTA in PBS for 10 min; fraction 3, 
1 mg/ml collagenase type Ⅱ in HBSS for 30 min) were retained. 
During the final digestion, the cells obtained from fractions 1 
and 2 were resuspended in αMEM supplemented with 10% 
heat-inactivated FCS (HI FCS), 5% gentamicin, 100 U/ml peni‑
cillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin. 
The cells from fraction 3 were then combined with fractions 1 
and 2 for expansion. The cells were cultured in 25 cm2 
flasks (1 calvariae/flask) or 75 cm2 flasks (3 calvaria/flask) for 
4-5 days in a humidified atmosphere of 5% CO2-95% air at 37˚C 
until confluent. To heat inactivate, FCS was treated at 55ºC for 
1 h. The above 2 protocols were each tested on both rat and 
mouse calvarial bone.
Osteoblast culture. Upon confluence, the cells were plated into 
24-, 12- or 6-well trays (Falcon®, BD Biosciences, Franklin 
Lakes, NJ, USA) at 2.5x104, 5x104 and 105 cells/well, respec‑
tively. To determine the optimal tissue culture medium for 
growing rodent osteoblasts, the cells were cultured in both 
DMEM and αMEM for up to 28 days. In contrast to DMEM, 
αMEM has a richer formulation, containing both essential and 
non-essential amino acids (including proline), nucleosides and 
ascorbate. DMEM (no. 11880), αMEM (no. 22571), FCS (batch 
tested: no. 102701) were obtained from Invitrogen Life 
Technologies. The effects of FCS heat inactivation (1 h at 55˚C), 
dexamethasone (10 nM) and β-glycerophosphate (0-10 mM) on 
the ability of the cells to form mature, bone‑forming osteoblasts 
were also examined.
All tissue culture media (i.e., including αMEM) were 
supplemented with 50 µg/ml ascorbate and the medium was 
half changed every 3 days. Medium pH, pCO2 and pO2 were 
monitored throughout the experiment using a blood gas anal‑
yser (ABL-705; Radiometer, Crawley, UK). The experiments 
were carefully pH‑controlled as osteoblast TNAP activity and 
bone mineralisation are extremely sensitive to inhibition by 
acidosis (9).
The responses of rat and mouse calvarial osteoblasts to 
the well-known inhibitors of bone mineralisation, inorganic 
pyrophosphate (PPi) and adenosine triphosphate (ATP) (8,11) 
were also compared in 14‑28‑day cultures.
Fixation, staining and analysis. The experiments were 
terminated by washing cell layers with PBS prior to fixation 
in 2.5% glutaraldehyde for 5 min. The cell layers were then 
washed twice with distilled water (dH2O) and left to air dry 
prior to staining. Mineralised nodules were stained with 2% 
alizarin red S (w/v), pH 4.5 in dH2O for 30 min followed by 
3 washes with dH2O. The TNAP staining of osteoblast cell 
layers (~30 min in the dark, followed by a wash with dH2O) was 
carried out using a commercially available kit (Sigma-Aldrich). 
All plates were allowed to air dry before scanning for analysis.
Mineralised bone nodule formation and TNAP expression 
were quantified by image analysis, as previously described (1).
Statistical analysis. Statistical comparisons (InStat; GraphPad 
Software, Inc., La Jolla, CA, USA) were made using both para‑
metric (one-way analysis of variance and adjusted using the 
Bonferroni method) and non-parametric Kruskall-Wallis and 
adjusted using the Dunn method tests. These methods yielded 
similar results (all figures where statistical significance is 
shown). Representative data are presented as the means ± SEM 
for 6 replicates. Results presented are for representative experi‑
ments that were each repeated at least 3 times.
Results
Bone formation by rat calvarial osteoblasts: effects of culture 
medium, dexamethasone and β‑glycerophosphate. Osteoblasts 
isolated from rat calvariae formed ‘trabecular‑shaped’ 
mineralised bone nodules that were clearly visible by the eye, 
and expressed significant amounts of TNAP when cultured in 
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both DMEM and αMEM. However, bone formation and TNAP 
expression were 2- to 3-fold higher in the cells cultured in αMEM 
than in the cells cultured in DMEM (Fig. 1A-C). The onset of 
mineralisation in the DMEM cultures occurred at day 10, with 
optimal bone formation at days 14-17, whereas the αMEM 
cultures showed marked acceleration, with mineralisation 
commencing at day 7 and striking bone formation observed 
between days 10-14. The heat inactivation of the FCS added 
to the culture media had no effect on mineralised bone nodule 
formation and TNAP staining.
Rat osteoblasts cultured in DMEM without dexametha‑
sone failed to form any bone and showed 3- to 4-fold lower 
TNAP expression (Fig. 1B and C). However, when the cells 
were cultured in αMEM without dexamethasone, some 
mineralised nodule formation was evident, albeit at greatly 
reduced (-85%) levels, compared to the cells cultured with 
dexamethasone (Fig. 1B). TNAP expression was unaltered by 
dexamethasone in the cells cultured in αMEM (Fig. 1C).
β-glycerophosphate, which is hydrolysed by TNAP, is 
widely used in osteoblast cultures as an inorganic phos‑
phate (Pi) source for mineralisation. The concentrations 
typically used vary from 2-10 mM. However, an excessive 
concentration of β-glycerophosphate (≥5 mM) has been shown 
to cause widespread, non-specific (‘dystrophic’) mineralisation, 
a phenomenon that differs greatly from true bone formation 
and is associated with reduced cell viability (1). We found that 
in the cells cultured in both DMEM and αMEM, mineralisation 
failed to occur in the absence of β-glycerophosphate (Fig. 2A). 
In the presence of 2 mM β‑glycerophosphate, selective miner‑
alisation of collagenous trabecular structures occurred in the 
cells cultured in both media, evidenced by intense alizarin 
red staining. At a concentration of 5 mM, β‑glycerophosphate 
caused the abundant, non‑specific deposition of mineral in 
the DMEM cells cultures but not in the αMEM cell cultures, 
perhaps reflecting the greater cellular activity in the latter 
medium. The widespread, non‑specific mineralisation of 
osteoblast cell layers was observed in both αMEM and DMEM 
cell cultures containing 10 mM β-glycerophosphate (Fig. 2A). 
Increasing the β‑glycerophosphate concentration above 2 mM 
also had a marked inhibitory effect on the amount of TNAP 
staining observed in the rat osteoblast cell layers, with reduc‑
tions of up to 3-fold observed (Fig. 2B and C).
Figure 1. Rat calvarial osteoblast cultures form bone more abundantly in αMEM. All cells were cultured in 50 µg/ml ascorbate and 2 mM β‑glycerophosphate. 
(A) The images are representative, whole well reflective light scans of rat osteoblast cell layers cultured using DMEM or αMEM supplemented with 10% fetal calf 
serum (FCS) or heat-inactivated FCS (HI FCS), with or without 10 nM dexamethasone. Cell layers are either unstained (white), stained with alizarin red to show 
bone mineralisation (red) or for tissue non-specific alkaline phosphatase (TNAP) expression (purple). Scale bar, 5 mm. (B) The level of bone mineralisation was 
3-fold higher in the cells cultured in αMEM compared to DMEM. In cultures without dexamethasone, bone mineralisation was 85% lower (αMEM) or completely 
absent (DMEM). Heat inactivation of FCS did not have an effect on the level of bone formation. (C) Levels of TNAP expression were 2.5-fold higher in the cells 
cultured in αMEM. The absence of dexamethasone had no effect on TNAP expression when the cells were grown in αMEM, but TNAP expression was reduced by 
3- to 4-fold in the cells cultured in DMEM. Heat inactivation of FCS did not affect TNAP expression. Values are the means ± SEM (n=6 replicate wells), ***p<0.001.
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Bone formation by mouse calvarial osteoblasts: effects of 
culture medium, dexamethasone and β‑glycerophosphate, 
and differences from rat osteoblasts. Osteoblasts from mouse 
calvariae also grew much more successfully in αMEM, such 
that bone formation was at least 3-fold higher than in the cells 
cultured in DMEM (Fig. 3A and B). The tissue culture medium 
also affected TNAP, the expression of which was up to 2-fold 
higher in the cells cultuerd in αMEM compared with the cells 
cultured in DMEM (Fig. 3A and C). There was a modest trend 
towards increased bone formation in the cell cultures supple‑
mented with HI FCS, compared with untreated FCS, although 
TNAP expression was not affected (Fig. 3B and C).
In contrast to the response of rat osteoblasts, the addition 
of 10 nM dexamethasone to the cell cultures reduced miner‑
alised bone formation by >90% (Fig. 3B). Surprisingly, TNAP 
expression was up to 3-fold higher in the cells treated with 
dexamethasone compared to the untreated cells.
The effects of β‑glycerophosphate on the mineralisation of 
mouse calvarial osteoblasts cultured in αMEM were broadly 
similar to those observed for rat osteoblasts. No mineralisation 
was observed in the absence of β-glycerophosphate; normal, 
selective mineralisation of the collagenous matrix occurred 
in the presence of 2-5 mM β‑glycerophosphate, whereas 
10 mM β‑glycerophosphate caused non‑specific, dystro‑
phic mineralisation and a significant inhibition of TNAP 
staining (Fig. 4A and B).
Optimal bone formation by mouse osteoblasts required 
~21-28 days, and was thus ~2-fold slower than for rat osteoblasts 
seeded at the same density. The individual bone structures 
formed by mouse osteoblasts were larger and more nodule-like 
than those formed by rat osteoblasts, although much less 
abundant (Fig. 5A-C). Mouse osteoblasts grew best in 6-well 
plates; in 12 or 24-well plates, marked peeling of the cell 
layers tended to occur before the onset of bone formation (data 
not shown). Rat osteoblasts, on the other hand, were cultured 
successfully in 6, 12 or 24-wells. Tissue culture plastics from 
several different manufacturers (BD Biosciences; Corning, Inc., 
Corning, NY, USA; Thermo Fisher Scientific, Inc., Waltham, 
MA, USA) were also tested: no significant differences in the 
level of bone formation were observed (data not shown).
Comparison of osteoblast isolation protocols with or without 
trypsin. Rodent osteoblasts were isolated using both TCC and 
CCEC digestion protocols and cultured in αMEM with HI FCS, 
50 µg/ml ascorbate and 2 mM β-glycerophosphate (plus 
10 nM dexamethasone for rat cells). We found that mature, 
bone-forming osteoblasts that expressed TNAP were gener‑
ated from rat and mouse calvarial cells using both methods, 
although the CCEC protocol appeared somewhat less efficient 
for rat cells (Fig. 6). The optimal conditions determined in 
this study for culturing bone‑forming rodent osteoblasts are 
summarised in Table I.
Figure 2. Excess β-glycerophosphate causes non-specific mineralisation and decreases tissue non-specific alkaline phosphatase (TNAP) expression in rat 
calvarial osteoblast cultures. All cells were cultured with heat-inactivated FCS (HI FCS), 50 µg/ml ascorbate and 10 mM dexamethasone. (A) Low power whole 
well scans and higher resolution phase contrast microscopy images showing alizarin red stained rat osteoblast cell layers cultured in DMEM or αMEM  with 
0-10 mM β-glycerophosphate. Without β‑glycerophosphate mineralisation did not occur, whilst 2 mM β‑glycerophosphate resulted in the selective mineralisa‑
tion of the collagenous matrix. Culture with ≥5 mM β-glycerophosphate resulted in non-specific dystrophic mineralisation, the levels of which were higher in the 
cells cultured in DMEM. Scale bars: whole well, 5mm; phase contrast micrographs, 500 µm. (B) In the cells cultured in αMEM, 5 and 10 mM β‑glycerophosphate 
reduced TNAP expression by 55 and 70%, respectively. (C) In DMEM, TNAP levels were decreased by 0 and 65% at 5 and 10 mM β‑glycerophosphate, respec‑
tively. Values are the means ± SEM (n=6 replicate wells), **p<0.01, ***p<0.001.
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Figure 3. Mouse calvarial osteoblasts require different culture conditions in order to form mineralised bone nodules in vitro from rat osteoblasts. All cells were 
cultured in 50 µg/ml ascorbate and 2 mM β-glycerophosphate. (A) The images are representative whole well reflective light scans of mouse osteoblast cell layers 
cultured using DMEM or αMEM supplemented with 10% fetal calf serum (FCS) or heat-inactivated FCS (HI FCS), with or without 10 nM dexamethasone. 
Cell layers are either unstained or stained with alizarin red to show bone mineralisation (red) or for tissue non-specific alkaline phosphatase (TNAP) expres‑
sion (purple). Scale bar, 5 mm. (B) Bone mineralisation was 4-fold higher when the cells were cultured in αMEM compared to DMEM. In cultures with 
dexamethasone, mineralisation was >80% lower. Using HI FCS resulted in a slight, non-significant increase in bone formation. (C) TNAP expression was ~50% 
higher in the cells cultured in αMEM. The absence of dexamethasone increased TNAP expression by up to 3-fold in cells cultured in both αMEM and DMEM. 
Using HI FCS did not affect TNAP expression. Values are the means ± SEM (n=6 replicate wells), *p<0.05, **p<0.01, ***p<0.001.
Figure 4. Excess β-glycerophosphate causes non-specific mineralisation and decreases tissue non-specific alkaline phosphatase (TNAP) expression in mouse 
calvarial osteoblast cultures. All cells were cultured in αMEM with heat-inactivated FCS (HI FCS) and 50 µg/ml ascorbate. (A) Low power whole well scans and 
higher resolution phase contrast microscopy images showing alizarin red stained mouse osteoblast cell layers cultured in αMEM with 0-10 mM β‑glycerophosphate. 
In the absence of β-glycerophosphate mineralisation does not occur, whilst 2-5 mM β‑glycerophosphate results in the selective mineralisation of the collagenous 
matrix. The 10 mM β-glycerophosphate results in widespread, non-specific dystrophic mineralisation of cell layers. Scale bars: whole well, 5 mm; phase contrast 
micrographs, 500 µm. (B) The 10 mM β-glycerophosphate reduced TNAP expression by 40%. Values are the means ± SEM (n=6 replicate wells), *p<0.05.
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The inhibitors of mineralisation, PPi and ATP, exert similar 
functional effects in cultures of rat and mouse osteoblasts. We 
compared the effects of the mineralisation inhibitors, PPi and 
ATP, in rat and mouse calvarial osteoblast cultures. Similar 
dose-dependent responses were observed for both species. PPi 
caused partial inhibition of mineralisation at a dose of 1 µM 
and near‑total inhibition at concentrations ≥10 µM, whereas 
ATP had a more graded effect, with near-total inhibition 
observed only at 100 µM (Fig. 7).
Discussion
The in vitro culture of rodent osteoblasts is a key research tool 
in bone biology. The increasingly widespread use of transgenic 
mouse models in research means that a reliable and effective 
method for culturing murine osteoblasts that results in the 
formation of discretely‑mineralised bone nodules is required. 
This study determined the optimal conditions required for 
the successful culture of rodent osteoblasts and identified a 
Figure 5. The mineralised bone nodules formed by rat osteoblasts are smaller but more abundant than mouse osteoblasts. All cells were cultured with heat-
inactivated FCS (HI FCS) and 50 µg/ml ascorbate and 2 mM β-glycerophosphate. (A) Phase contrast microscopy images highlight the significant differences 
in the size and number of bone nodules formed by rodent osteoblasts. Images show unstained (white), alizarin red (red) and tissue non-specific alkaline phos‑
phatase (TNAP) (purple) stained bone nodules. Scale bar, 500 µm. (B) The number of mineralised bone nodules formed in cultures of rat osteoblasts was 6-fold 
higher than mouse osteoblasts. (C) The size of the bone nodules formed was 2-fold higher in mouse osteoblast cultures. Values are the means ± SEM (n=6 
replicate wells), **p<0.01, ***p<0.001.
Figure 6. Tissue culture conditions are more important to the success of the culture than the initial method of obtaining cells. In order to determine how important 
the method of isolation is in the success of the culture, rodent cells were obtained using both the trypsin-collagenase-collagenase (TCC) and collagenase-col‑
lagenase-EDTA-collagenase (CCEC) digestion protocols. Cells were cultured in αMEM with heat inactivated FCS (HI FCS), 50 µg/ml ascorbate and 2 mM 
β-glycerophosphate (plus 10 nM dexamethasone, rat only) for up to 28 days. Mature, mineralising osteoblasts were generated from rat and mouse calvarial 
cells using both isolation methods. (A) The level of bone formation and tissue non-specific alkaline phosphatase (TNAP) expression were 25 and 35% lower, 
respectively, in rat cells obtained using CCEC digestion. (B) The method of isolation did not affect the level of bone mineralisation or TNAP expression in mouse 
osteoblasts. Values are the means ± SEM (n=6 replicate wells), **p<0.01.
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number of key differences between rat and mouse cells which 
need to be taken into account for future study (Table I).
Significant differences in the behaviour of rat and mouse 
osteoblasts in vitro were observed. Rat osteoblast cultures were 
considerably shorter in duration typically being ~14 days, whilst 
mouse osteoblasts required a minimum of 21 days in order to 
form mineralised matrix nodules. There were also marked 
differences in the appearance of the bone that was formed; 
rat osteoblasts typically produced smaller bone nodules that 
had a ‘trabecular‑shaped’ appearance. By contrast, in mouse 
osteoblast cultures, the bone nodules were larger but fewer in 
number.
This study compared the effects of two different culture 
media, a basic DMEM and a more nutrient‑rich αMEM. The 
formulation of αMEM is designed to closely approximate 
the protein composition of cells (12) and contains a higher 
concentration of amino acids and nucleotides than DMEM. 
Abundant bone mineralisation and TNAP expression was 
evident when rat calvarial osteoblasts were cultured in both 
DMEM and αMEM. However, cells cultured in αMEM formed 
more bone, expressed higher levels of TNAP and began to 
mineralise more rapidly (after ~7 days in culture compared 
to ~10 days for DMEM). Thus, by culturing in αMEM, the 
efficiency of the cultures was increased and the overall duration 
of the experiment was reduced. This increased osteogenic 
activity of rat osteoblasts cultured in αMEM is most likely 
due to the richer formulation of the medium. It is noteworthy 
that proline and ascorbate, which are required for collagen 
synthesis, are both constituents of αMEM but not DMEM. By 
contrast, mouse osteoblasts showed lower osteogenic activity 
and significant bone formation was observed only in αMEM 
cultures. This suggests that mouse osteoblasts may require more 
nutritional support in vitro than rat osteoblasts. In addition to 
the experiments described in this study using osteoblasts from 
129/sv mice (an inbred strain), we also successfully cultured 
bone-forming osteoblasts from C57BL/6 mice in αMEM, with 
no significant differences observed (data not shown).
FCS contains numerous growth factors and proteins which 
promote cell growth and survival and is a key supplement to 
tissue culture media. The heat inactivation of FCS is typically 
performed to degrade heat‑labile components, such as comple‑
ment (13), but it may also denature other proteins present in 
the serum. Our experiments indicated that the heat inactiva‑
tion of serum had no detectable impact on either rat or mouse 
osteoblast cultures.
Dexamethasone was first shown to promote the differentia‑
tion of rat calvarial osteoblasts by Bellows et al in the 1980s (7). 
In agreement with their study, we found that rat bone cells 
cultured in DMEM required dexamethasone in order to form 
Figure 7. The inhibitors of mineralisation, inorganic pyrophosphate (PPi) and ATP, exert similar functional effects in cultures of rat and mouse osteoblasts. 
In rat osteoblasts, (A) PPi and (B) adenosine triphosphate (ATP) inhibited mineralisation from 1 and 10 µM, respectively. At 100 µM mineralisation was 
decreased by >98%. In mouse osteoblasts, both (C) PPi and (D) ATP blocked mineralisation from concentrations of 1 µM. At 100 µM, mineralisation was 
completely abolished. Values are the means ± SEM (n=6 replicate wells), **p<0.01, ***p<0.001.
Table I. Summary of the optimal conditions for culturing bone‑ 
forming rodent osteoblasts.
Conditions Rat Mouse
Cell isolation protocol TCC TCC or CCEC
Cell yield/calvariae (after 7x106-107 3-5x106
expansion for 2-3 days)  
Basal medium DMEM or αMEM αMEM
 Cultures 3-4 days 
 shorter in αMEM 
FCS 10% FCS or 10% FCS or
 HI FCS HI‑FCS
Dexamethasone 10 nM Not required
β-glycerophosphate 2 mM 2-5mM
Ascorbate 50 µg/ml 50 µg/ml
Plate format 6-, 12- or 6-well plates
 24‑well plates 
Culture duration 14-17 days in DMEM 21-28 days
 10-14 days in αMEM 
TCC, trypsin-collagenase-collagenase; CCEC, collagenase-collagenase-EDTA- 
collagenase.
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mineralised bone nodules and express significant amounts of 
TNAP. However, small amounts of bone formation did occur in 
the absence of dexamethasone when the rat cells were cultured 
in αMEM, reflecting the more strongly osteogenic properties 
of this medium. Surprisingly, TNAP expression by rat cells 
was unaffected by the presence or absence of dexamethasone 
in αMEM.
It has been previously demonstrated that dexamethasone 
inhibits proliferation and osteogenic differentiation in mouse 
osteoblast cultures (14,15). We also found that the addition of 
dexamethasone inhibited bone formation by mouse osteoblasts; 
this was associated with an increased TNAP expression after 
28 days of culture. This observation may well be consistent 
with an inhibitory effect of dexamethasone on osteogenesis as 
TNAP expression has been reported to peak prior to the onset 
of bone formation in primary osteoblast cultures (8,16).
β‑glycerophosphate, a widely used supplement in osteoblast 
tissue culture medium, is hydrolysed by TNAP to provide 
the Pi required for mineralisation. The concentrations typi‑
cally used range between 2 and 10 mM. A previous study 
indicated that in rat osteoblast cultures, excessive amounts of 
β-glycerophosphate (≥5 mM) reduce cell viability and cause 
widespread, non-specific mineral deposition that differs greatly 
from true bone formation (1). The present study demonstrates 
that extensive dystrophic mineralisation also occurs when 
mouse osteoblasts are cultured with excessive amounts of 
β-glycerophosphate (10 mM). The higher tolerance of mouse 
osteoblasts to β-glycerophosphate may reflect differences in 
basal TNAP activity. In both rat and mouse osteoblasts, the 
concentrations of β-glycerophosphate that caused non-specific 
mineralisation also resulted in decreased TNAP expression. 
This may be due to the inhibition of the enzymatic activity of 
TNAP by Pi (17) or to the general detrimental effects of dystro‑
phic mineralisation on cell viability (1).
We compared two different protocols for isolating osteo‑
blasts from rodent calvariae. The first method, TCC, utilises 
only the cells from the final collagenase digestion (1). The 
second method, CCEC, retains and pools the cells from three 
of the four digestions (18). We found that both protocols were of 
broadly similar efficacy in generating mature, TNAP-positive, 
bone forming osteoblasts from both rat and mouse calvariae. 
Thus, it appears that the tissue culture conditions (i.e., media 
and supplements) are more important for osteogenesis than the 
initial method of obtaining cells.
PP i and ATP are well-known inhibitors of bone 
mineralisation (8,11). In the present study, we demonstrate 
that low micromolar concentrations of PPi and ATP block the 
mineralisation of the collagenous matrix in cultures of both 
rat and mouse osteoblasts; ATP was approximately an order 
of magnitude more potent in mouse osteoblasts. ATP inhibits 
bone mineralisation by two distinct mechanisms: signalling via 
P2 receptors and through the breakdown of ATP by NPP1 to 
produce PPi (8). Thus, the increased potency of ATP in mouse 
osteoblasts may reflect a higher expression of P2 receptors or 
of NPP1.
The results presented herein, based on simple methods, 
should prove useful not only for laboratories wishing to 
establish osteogenic cultures of mouse osteoblasts, but also 
for those requiring a more effective technique for culturing 
bone‑forming rat osteoblasts.
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